196 related articles for article (PubMed ID: 26957672)
1. Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.
Paulukonis ST; Eckman JR; Snyder AB; Hagar W; Feuchtbaum LB; Zhou M; Grant AM; Hulihan MM
Public Health Rep; 2016; 131(2):367-75. PubMed ID: 26957672
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
[TBL] [Abstract][Full Text] [Related]
3. Population estimates of sickle cell disease in the U.S.
Hassell KL
Am J Prev Med; 2010 Apr; 38(4 Suppl):S512-21. PubMed ID: 20331952
[TBL] [Abstract][Full Text] [Related]
4. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002.
Yanni E; Grosse SD; Yang Q; Olney RS
J Pediatr; 2009 Apr; 154(4):541-5. PubMed ID: 19028391
[TBL] [Abstract][Full Text] [Related]
5. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH).
Paulukonis ST; Harris WT; Coates TD; Neumayr L; Treadwell M; Vichinsky E; Feuchtbaum LB
Pediatr Blood Cancer; 2014 Dec; 61(12):2271-6. PubMed ID: 25176145
[TBL] [Abstract][Full Text] [Related]
6. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005.
Lanzkron S; Carroll CP; Haywood C
Public Health Rep; 2013; 128(2):110-6. PubMed ID: 23450875
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening Program.
Sabarense AP; Lima GO; Silva LM; Viana MB
J Pediatr (Rio J); 2015; 91(3):242-7. PubMed ID: 25449790
[TBL] [Abstract][Full Text] [Related]
8. Mortality of New York children with sickle cell disease identified through newborn screening.
Wang Y; Liu G; Caggana M; Kennedy J; Zimmerman R; Oyeku SO; Werner EM; Grant AM; Green NS; Grosse SD
Genet Med; 2015 Jun; 17(6):452-9. PubMed ID: 25255366
[TBL] [Abstract][Full Text] [Related]
9. National trends in the mortality of children with sickle cell disease, 1968 through 1992.
Davis H; Schoendorf KC; Gergen PJ; Moore RM
Am J Public Health; 1997 Aug; 87(8):1317-22. PubMed ID: 9279267
[TBL] [Abstract][Full Text] [Related]
10. Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease.
Snyder AB; Zhou M; Theodore R; Quarmyne MO; Eckman J; Lane PA
Public Health Rep; 2019; 134(3):274-281. PubMed ID: 30970223
[TBL] [Abstract][Full Text] [Related]
11. Opioids are not a major cause of death of patients with sickle cell disease.
Ballas SK
Ann Hematol; 2021 May; 100(5):1133-1138. PubMed ID: 33758998
[TBL] [Abstract][Full Text] [Related]
12. Mortality of children with sickle cell disease: a population study.
Fernandes AP; Januário JN; Cangussu CB; Macedo DL; Viana MB
J Pediatr (Rio J); 2010; 86(4):279-84. PubMed ID: 20508908
[TBL] [Abstract][Full Text] [Related]
13. Case Ascertainment of Sickle Cell Disease Using Surveillance or Single Administrative Database Case Definitions.
Reeves SL; Horiuchi S; Zhou M; Paulukonis S; Snyder A; Wilson-Frederick S; Hulihan M
Public Health Rep; 2024; 139(2):187-194. PubMed ID: 37204194
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
Paulukonis ST; Snyder A; Smeltzer MP; Sutaria AN; Hurden I; Latta K; Chennuri S; Vichinsky E; Reeves SL
J Pediatr Hematol Oncol; 2023 May; 45(4):174-180. PubMed ID: 37083273
[TBL] [Abstract][Full Text] [Related]
15. Medical care utilization and mortality in sickle cell disease: a population-based study.
Shankar SM; Arbogast PG; Mitchel E; Cooper WO; Wang WC; Griffin MR
Am J Hematol; 2005 Dec; 80(4):262-70. PubMed ID: 16315251
[TBL] [Abstract][Full Text] [Related]
16. Mortality and Causes of Death From Sickle Cell Disease in The Netherlands, 1985-2017.
Rettenbacher E; Zaal J; Heijboer H; van der Plas EM; Hof M; Biemond BJ; Fijnvandraat K;
J Pediatr Hematol Oncol; 2021 Oct; 43(7):258-265. PubMed ID: 34001787
[TBL] [Abstract][Full Text] [Related]
17. Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.
Payne AB; Link-Gelles R; Azonobi I; Hooper WC; Beall BW; Jorgensen JH; Juni B; Moore M;
Pediatr Infect Dis J; 2013 Dec; 32(12):1308-12. PubMed ID: 23811745
[TBL] [Abstract][Full Text] [Related]
18. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.
Payne AB; Mehal JM; Chapman C; Haberling DL; Richardson LC; Bean CJ; Hooper WC
Ann Emerg Med; 2020 Sep; 76(3S):S28-S36. PubMed ID: 32928459
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.
Singh A; Sontag MK; Zhou M; Dasgupta M; Crume T; McLemore M; Galadanci N; Randall E; Steiner N; Brandow AM; Koch K; Field JJ; Hassell K; Snyder AB; Kanter J
JMIR Public Health Surveill; 2023 Jun; 9():e42816. PubMed ID: 37379070
[TBL] [Abstract][Full Text] [Related]
20. Mortality in sickle cell disease: A population-based study in an aboriginal community in the Gudalur Valley, Nilgiris, Tamil Nadu, India.
Sheshadri V; Shabeer P; Santhirapala V; Jayaram A; Krishnamurti L; Menon N
Pediatr Blood Cancer; 2021 Mar; 68(3):e28875. PubMed ID: 33381914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
